These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

955 related articles for article (PubMed ID: 34631603)

  • 1. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
    Xiao L; Liu Q; Luo M; Xiong L
    Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
    mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome.
    Deng X; Xiao L; Luo M; Xie P; Xiong L
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1072-1082. PubMed ID: 36869260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
    Shaidullov IF; Sorokina DM; Sitdikov FG; Hermann A; Abdulkhakov SR; Sitdikova GF
    BMC Gastroenterol; 2021 Jan; 21(1):37. PubMed ID: 33499840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 7. Bile acid-gut microbiota crosstalk in irritable bowel syndrome.
    Gu Y; Li L; Yang M; Liu T; Song X; Qin X; Xu X; Liu J; Wang B; Cao H
    Crit Rev Microbiol; 2023 May; 49(3):350-369. PubMed ID: 35389754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome.
    O'Malley D
    Exp Physiol; 2019 Jan; 104(1):3-10. PubMed ID: 30444291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis.
    Luo M; Zhuang X; Tian Z; Xiong L
    BMC Gastroenterol; 2021 Jan; 21(1):14. PubMed ID: 33407171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome: a gut microbiota-related disorder?
    Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of
    Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
    Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review.
    Hou JJ; Wang X; Wang YM; Wang BM
    Crit Rev Microbiol; 2022 Nov; 48(6):696-713. PubMed ID: 34936854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice.
    Cheng F; Fan Z; Lin C; Zhu Y; He H; Dai N; Du L
    Eur J Gastroenterol Hepatol; 2022 Dec; 34(12):1220-1230. PubMed ID: 36165068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome.
    Jiang W; Wu J; Zhu S; Xin L; Yu C; Shen Z
    J Neurogastroenterol Motil; 2022 Oct; 28(4):540-548. PubMed ID: 36250361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome.
    Zhan K; Zheng H; Li J; Wu H; Qin S; Luo L; Huang S
    Biomed Res Int; 2020; 2020():3828249. PubMed ID: 33274207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

  • 19. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.
    Mishima Y; Ishihara S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.